TD Cowen Lowers Procter & Gamble (NYSE:PG) Price Target to $150.00

Procter & Gamble (NYSE:PG) had its price objective lowered by analysts at TD Cowen from $168.00 to $150.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 5.77% from the company’s previous close.

Other analysts have also recently issued reports about the stock. BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Cowen restated a “buy” rating on shares of Procter & Gamble in a research report on Thursday. UBS Group cut their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Wells Fargo & Company decreased their price objective on Procter & Gamble from $170.00 to $158.00 and set an “overweight” rating on the stock in a research note on Monday, January 5th. Finally, Piper Sandler started coverage on Procter & Gamble in a research note on Wednesday. They issued a “neutral” rating and a $150.00 target price for the company. Fifteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $169.23.

Procter & Gamble Stock Performance

Shares of PG opened at $141.81 on Thursday. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $179.99. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. The stock’s fifty day moving average price is $144.93 and its two-hundred day moving average price is $151.57. The firm has a market cap of $331.37 billion, a PE ratio of 20.70, a PEG ratio of 4.77 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter in the prior year, the company earned $1.93 EPS. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, equities research analysts forecast that Procter & Gamble will post 6.91 EPS for the current year.

Insiders Place Their Bets

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares in the company, valued at $146,429.03. The trade was a 42.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.20% of the stock is owned by corporate insiders.

Institutional Trading of Procter & Gamble

Hedge funds have recently made changes to their positions in the stock. Halbert Hargrove Global Advisors LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter worth about $25,000. Nova Wealth Management Inc. bought a new stake in Procter & Gamble in the 1st quarter worth approximately $26,000. Signature Resources Capital Management LLC boosted its stake in Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after buying an additional 72 shares in the last quarter. Saranac Partners Ltd bought a new position in Procter & Gamble during the third quarter valued at approximately $30,000. Finally, Corundum Trust Company INC purchased a new position in shares of Procter & Gamble during the third quarter worth approximately $32,000. 65.77% of the stock is owned by institutional investors.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Seeking Alpha argues the market is wrong and P&G is a buy — the piece upgrades the rating, highlighting durable cash flows and long-term compounding potential that could attract value investors. Procter & Gamble: The Market Is Wrong – It’s Time To Buy This Compounder (Rating Upgrade)
• Positive Sentiment: TD Cowen cut its price target (to $150) but maintained a Buy — signals some near-term valuation cooling yet continued analyst conviction that P&G has upside from current levels. Benzinga
• Neutral Sentiment: Zacks notes P&G is a trending stock and summarizes factors investors should watch (demand trends, promotions, dividend profile), useful for short-term traders but not a firm directional catalyst. Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Analysis on Yahoo Finance frames the story as a trade-off: legal scrutiny vs. new CEO emphasis on pricing — legal risk raises uncertainty, but stronger pricing execution would support margins and investor confidence. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
• Negative Sentiment: Regulatory action: P&G agreed to change Crest kids’ toothpaste packaging after concerns raised by the Texas AG — this creates near-term legal/regulatory overhang and potential reputational risk. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
• Negative Sentiment: Wells Fargo trimmed its price target (to $158 from $170) as 2026 models were reset — the cut, even with an Overweight call, signals lower near-term upside from previous analyst expectations. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
• Negative Sentiment: Market-watch pieces and a Seeking Alpha “still not a buy” write-up highlight valuation concerns (multiples vs. growth) and recent softness in category demand — these narratives feed selling pressure and explain continued volatility. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
• Negative Sentiment: Short-term technical/market signal: coverage flagged P&G hitting a 52-week low recently, which can amplify downside momentum as momentum traders and funds react. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.